Conditions: Epidermolysis Bullosa
Keywords: Epidermolysis bullosa
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 8
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine how safe and effective allantoin 3% cream (Alwextin) is in improving the healing of recurrent skin lesions and reducing overall blistering in people with epidermolysis bullosa (EB). Allantoin 3% cream is applied topically to the entire body once daily.

Detailed description:
Potential subjects came to the for a screening visit. Eligible subjects had baseline assessments performed and were provided study medication, allantoin 3% cream. Subjects were instructed to apply the study medication to the entire body once daily and to keep daily record of study medication use. Subjects returned every 4 weeks for a total of 12 weeks for repeat assessments.

Arms:
arm 1: 8 subjects enrolled in this single study arm. All 8 subjects completed the study.

Interventions: intervention 1: Alwextin cream
Intervention descriptions: intervention 1: Alwextin cream contains active ingredient, allantoin 3%. Use 1 application daily for 3 month duration.

Protocol document: